Approval for insurance coverage and start of sales for the treatment app Medcle planned to commence in June 2026; sales will be handled in-house; focus on progress of the development pipeline and trends in sales partnerships.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4263","jir_company_name":"Sasmade Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-17","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4263-20260917-02.pdf","jir_short_summary":"Approval for insurance coverage and start of sales for the treatment app Medcle planned to commence in June 2026; sales will be handled in-house; focus on progress of the development pipeline and trends in sales partnerships.","jir_summary":"### Section Heading\nThis IR centers on the sale start of Medcle, a treatment app utilizing Sasmade's DTx platform, and the status of the pipeline, reporting progress on insurance listing and establishment of service provision to medical institutions. It also discusses the growth potential of the DTx market, considerations for insurance reimbursement and reimbursement pricing, and domestic market estimates, clarifying the business viability and competitive landscape of treatment apps.\n\n### Section 2 Heading\nThe document describes the monetization path from the sales start, the progress of the development pipeline (SMD201\/105\/403, etc.), and the policy and outlook for risks (funding, intellectual property, partner developments).","jir_financial_highlights":"Sales start timing: June 2026 (Unknown)\nMilestone: JPY 200,000,000 to be received (to be recognized in the June 2027 term) (Projected to recognize new revenue)\nPharmacist Act-related: Insurance coverage claim filed (Progress)","jir_category":"","jir_hashtags":"#in-house_product, #DTx, #treatment_app, #Medcle, #sales_start, #insurance_listing, #partnership_dissolution","jir_key_figures":"Sales start timing: June 2026\nMedcle milestone: 200,000,000 yen to be received (to be recognized in the June 2027 term)\nEnd of sales partnership with Shionogi: August 2026\nInsurance coverage request submitted: Based on information for the fiscal year ending September 2026","jir_meta_title":"\u3010Sasmade Co., Ltd.\u3011 Insurance Listing and Sales Start for Treatment App Medcle | June 2026","jir_meta_description":"Sasmade's treatment app Medcle receives insurance listing approval and begins sales to medical institutions from June. Attention on progress of the development pipeline, strengthening of the sales framework, and movements in partnerships.","jir_og_title":"Sasmade's Treatment App Medcle to Start Sales | June 2026","jir_og_description":"Announcement of insurance listing and sales start for Medcle. Focus on pipeline progress, monetization outlook, and partnership movements.","jir_og_image_url":"\/assets\/og\/company-business_update.jpg","jir_chart_data_collection":"[]","ir_related_company":58337,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"business_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-114814","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n